ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2009;88:397-398. doi:10.1016/j.athoracsur.2009.06.001
© 2009 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Lorenzo Spaggiari
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spaggiari, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spaggiari, L.
Related Collections
Right arrow Lung - cancer
Right arrow Mediastinum
Right arrowRelated Article

Original Articles: General Thoracic

Invited Commentary

Lorenzo Spaggiari, MD, PhD

Department of Thoracic Surgery, European Institute of Oncology, Via Ripamonti 435, Milan, 20141 Italy

(Email: lorenzo.spaggiari@ieo.it).

The first 20% of the full text of this article appears below.

The article by Lanuti and colleagues [1] is important not only in terms of content but also because it offers further evidence that superior vena cava (SVC) resection is indicated to treat pulmonary and mediastinal malignancies. Technically speaking, the article confirms the feasibility of resection without cardiopulmonary support in all patients if selection is appropriate.

I would like to add our personal contribution on a biologic prosthesis we routinely use in all patients undergoing SVC resection. Our first patient with lung cancer to receive a bovine pericardial tube was operated on in 2003. He is still alive without any anticoagulant regimen, with a fully patent prosthesis, and no graft calcification. To date, we have used . . . [Full Text of this Article]


Related Article

Review of Superior Vena Cava Resection in the Management of Benign Disease and Pulmonary or Mediastinal Malignancies
Michael Lanuti, Pierre E. De Delva, Henning A. Gaissert, Cameron D. Wright, John C. Wain, James S. Allan, Dean M. Donahue, and Douglas J. Mathisen
Ann. Thorac. Surg. 2009 88: 392-397. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The Society of Thoracic Surgeons.